Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR).
Publication
, Journal Article
Godier, A; Fontana, P; Motte, S; Steib, A; Bonhomme, F; Schlumberger, S; Lecompte, T; Rosencher, N; Susen, S; Vincentelli, A; Gruel, Y ...
Published in: Arch Cardiovasc Dis
March 2018
Duke Scholars
Published In
Arch Cardiovasc Dis
DOI
EISSN
1875-2128
Publication Date
March 2018
Volume
111
Issue
3
Start / End Page
210 / 223
Location
Netherlands
Related Subject Headings
- Treatment Outcome
- Thrombosis
- Risk Factors
- Postoperative Hemorrhage
- Platelet Aggregation Inhibitors
- Humans
- Hemostasis
- France
- Elective Surgical Procedures
- Drug Administration Schedule
Citation
APA
Chicago
ICMJE
MLA
NLM
Godier, A., Fontana, P., Motte, S., Steib, A., Bonhomme, F., Schlumberger, S., … French Working Group on perioperative hemostasis (GIHP), . (2018). Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR). Arch Cardiovasc Dis, 111(3), 210–223. https://doi.org/10.1016/j.acvd.2017.12.004
Godier, Anne, Pierre Fontana, Serge Motte, Annick Steib, Fanny Bonhomme, Sylvie Schlumberger, Thomas Lecompte, et al. “Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR).” Arch Cardiovasc Dis 111, no. 3 (March 2018): 210–23. https://doi.org/10.1016/j.acvd.2017.12.004.
Godier A, Fontana P, Motte S, Steib A, Bonhomme F, Schlumberger S, et al. Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR). Arch Cardiovasc Dis. 2018 Mar;111(3):210–23.
Godier, Anne, et al. “Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR).” Arch Cardiovasc Dis, vol. 111, no. 3, Mar. 2018, pp. 210–23. Pubmed, doi:10.1016/j.acvd.2017.12.004.
Godier A, Fontana P, Motte S, Steib A, Bonhomme F, Schlumberger S, Lecompte T, Rosencher N, Susen S, Vincentelli A, Gruel Y, Albaladejo P, Collet J-P, French Working Group on perioperative hemostasis (GIHP). Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR). Arch Cardiovasc Dis. 2018 Mar;111(3):210–223.
Published In
Arch Cardiovasc Dis
DOI
EISSN
1875-2128
Publication Date
March 2018
Volume
111
Issue
3
Start / End Page
210 / 223
Location
Netherlands
Related Subject Headings
- Treatment Outcome
- Thrombosis
- Risk Factors
- Postoperative Hemorrhage
- Platelet Aggregation Inhibitors
- Humans
- Hemostasis
- France
- Elective Surgical Procedures
- Drug Administration Schedule